OneFlow and South Park Commons provide cash for Cent, the founder of Practo's health firm

Healthtech startup Cent, founded by Shashank ND along with Arpit Garg and Anshul Khandelwal, has raised an undisclosed amount in funding from OneFlow Holdings, the family office of Shashank ND, and venture firm South Park Commons. The company aims to build an AI-led platform focused on early detection of serious diseases.

Cent focuses specifically on identifying life-threatening conditions such as cancer, cardiac and metabolic diseases at an early stage. According to cofounder and chief business officer Anshul Khandelwal, these diseases account for about 70–74% of deaths globally, making early diagnosis critical.

Unlike many healthcare startups in India that operate in a business-to-business model, Cent follows a direct-to-consumer (D2C) approach. The company provides services directly to individuals and does not earn commissions from hospitals, doctors or insurance companies.

The Bengaluru-based startup has been operational since the first quarter of FY26 and has already completed more than 1,500 diagnostic scans. According to the company, about 26% of scans revealed clinically meaningful findings, while 3–4% detected critical conditions such as cancer or severe heart blockages, even in people who showed no symptoms.

The idea for Cent came from personal experiences within the founding team. Both Khandelwal and Shashank ND lost family members to cancer, which motivated them to build a system focused on detecting diseases earlier.

Cent’s technology is based on a proprietary screening protocol called CCNM (cardiac, cancer, neurological and metabolic). The system combines several diagnostic tools including full-body MRI, cardiac CT scans, ECG, DEXA scans, more than 120 blood and urine biomarkers and genomic testing. The collected data is analyzed using artificial intelligence and reviewed by medical specialists to generate a detailed report of around 60–70 pages, including an organ-level health score.

The company evaluates its system using a metric called the Early Detection Index (EDI). Cent claims an EDI score of about 83%, compared with roughly 15–20% for traditional annual health checkups.

The startup said it is currently growing around 50% month-on-month and has reached an annualised revenue run rate of about $2 million.

With the newly raised capital, Cent plans to open dedicated early detection centres across major Indian cities. The first centre is expected to launch in Bengaluru in April, followed by expansion into Mumbai, Delhi and Hyderabad.

Cent also plans to raise a Series A funding round, expected to be five to six times larger than the seed round, to support further expansion and potential international growth.

Globally, several startups are building similar preventive healthcare platforms using AI, including Prenuvo, Function Health and Neko Health, reflecting growing interest in technology-driven medical diagnostics.